Cows Milk Allergy
40
2
3
18
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
4 terminated out of 40 trials
81.8%
-4.7% vs benchmark
5%
2 trials in Phase 3/4
17%
3 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (40)
Pasteurised Donor Human Milk Supplementation for Term Babies
Early Supplementation for Cow's Milk Allergy Prevention
Infant Formula in Infants and Children With Cow's Milk Allergy
Synbiotics Cohort Study
Baked Milk Oral Immunotherapy for Cow's Milk Allergy
Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.
The Incidence of Venous Thromboembolism in Atopic Dermatitis
Hypoallergenicity of a New Formula in Subjects With Cow's Milk Allergy
Hypoallergenicity of a Hydrolyzed Protein Infant Formula
Validity of Cow's Milk-related Symptom Score Among Children Suspected to Have Cow's Milk Protein Alergy
Neokare Safety and Tolerability Assessment in Neonates With GI Problems
Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children
Extensively Hydrolyzed Infant Formula in Infants and Children With Cow's Milk Allergy
Infant Formula Feeding and Necrotizing Enterocolitis in Newborns
Diagnosis of Cow's Milk Protein Allergy
Study to Assess Hypoallergenicity of a New Amino-acid Based Infant Formula in Children With Cow's Milk Allergy
Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy
The Effect of Baked Milk on Cow's Milk Allergy
Epigenetic Effects Involved in Children With Cow's Milk Allergy (EPICMA)
Evaluation of Hypoallergenicity of a New Extensively Hydrolyzed Formula